GlycoMimetics, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 133
Rang # Quantité totale PI 9 732
Note d'activité PI 2,7/5.0    73
Rang # Activité PI 9 661
Symbole boursier
ISIN US38000Q1022
Capitalisation 19.50M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

57 3
18 1
51 1
2
 
Dernier brevet 2024 - Polar cd33 ligands suitable for ...
Premier brevet 1992 - Compositions and methods for end...
Dernière marque 2023 - RUPTMEZO
Première marque 2013 - GLYCOMIMETICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists. Compounds, compositions, and ...
Invention Heterobifunctional inhibitors of e-selectin and galectin-3. Compounds, compositions, and methods...
P/S pharmaceuticals for the treatment of acute myeloid leukemia and other cancers; anti-cancer prepar...
P/S Pharmaceuticals for the treatment of acute myeloid leukemia and other cancers; anti-cancer prepar...
Invention Highly potent multimeric e-selectin antagonists. Compounds, compositions, and methods for treatm...
Invention Methods for treating acute myeloid leukemia and related conditions. Methods for treating or inhi...
Invention Methods of mobilizing marrow infiltrating lymphocytes and uses thereof. Methods are disclosed fo...
2022 Invention Polar cd33 ligands suitable for incorporation into carriers. CD33 ligands which are useful for t...
Invention Compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targe...
Invention Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heter...
Invention Galectin-3 inhibiting c-glycoside oximes. Compounds of formula (I), compositions, and methods fo...
Invention Galectin-3 inhibiting c-glycosides. Compounds of formula (I), compositions, and methods for trea...
Invention Galectin-3 inhibiting c-glycoside oximes. Compounds of formula (I), compositions, and methods for...
Invention Galectin-3 inhibiting c-glycosides. Compounds of formula (I), compositions, and methods for treat...
Invention E-selectin antagonist compounds, compositions, and methods of use. Methods and compositions using...
Invention Process for preparing an e-selectin inhibitor intermediate. A process is provided for the synthe...
Invention Process for preparing an e-selectin inhibitor intermediate. A process is provided for the synthes...
2021 Invention Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists. Compounds, compositions, and m...
Invention E-selectin targeting agents. E-selectin ligands which are useful for the synthesis of E-selectin...
Invention E-selectin targeting agents. E-selectin ligands which are useful for the synthesis of E-selectin ...
Invention Highly potent multimeric e-selectin antagonists. Compounds, compositions, and methods for treatme...
Invention Compounds and methods for reduction of cancer cell burden and protection of normal hematopoiesis....
Invention Cd33 ligands suitable for incorporation into carriers. CD33 ligands which are useful for the syn...
Invention Cd33 ligands suitable for incorporation into carriers. CD33 ligands which are useful for the synt...
Invention Treatment of acute respiratory distress syndrome and related conditions with antagonists of e-sel...
2020 Invention Galectin-3 inhibiting c-glycoside ketones, ethers, and alcohols. Compounds, compositions, and me...
Invention Galectin-3 inhibiting c-glycoside ketones, ethers, and alcohols. The application relates to galec...
Invention Use of e-selectin antagonists to enhance the survival of reconstituted, bone marrow-depleted host...
Invention Use of highly potent multimeric e-selectin antagonists for treating sickle cell disease. Methods...
Invention Use of highly potent multimeric e-selectin antagonists for treating sickle cell disease. Methods ...
Invention Methods for use of gene expression as an indicator of e-selectin inhibitor efficacy and clinical ...
Invention Galactose-linked multimeric glycomimetic inhibitors of e-selectins, galectin-3, and/or cxcr4 chem...
Invention Multimeric pan-selectin antagonists. Compounds, compositions, and methods for modulating in vitr...
2019 Invention Heterobifunctional inhibitors of e-selectin and galectin-3. Compounds, compositions, and methods ...
Invention Galectin-3 inhibiting c-glycosides. Compounds, compositions, and methods for treatment and/or pre...
Invention Methods for treating acute myeloid leukemia and related conditions. Methods for treating or inhib...
2018 Invention Methods of mobilizing marrow infiltrating lymphocytes and uses thereof. Methods are disclosed for...
2014 P/S Research and development in the pharmaceutical and biotechnology fields.
P/S Research and development in the pharmaceutical and biotechnology fields.
2013 P/S Research and development in the pharmaceutical and biotechnology fields